{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:14:04Z","timestamp":1781720044954,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00383-021-05009-7","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T10:29:38Z","timestamp":1632220178000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Elevation of microRNA-214 is associated with progression of liver fibrosis in patients with biliary atresia"],"prefix":"10.1007","volume":"38","author":[{"given":"Tomohisa","family":"Yoneyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-8814","authenticated-orcid":false,"given":"Takehisa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Masahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyoshi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Tazuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Oue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"5009_CR1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/S0140-6736(09)60946-6","volume":"374","author":"JL Hartley","year":"2009","unstructured":"Hartley JL, Davenport M, Kelly DA (2009) Biliary atresia. Lancet 374:1704\u20131713","journal-title":"Lancet"},{"key":"5009_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.yapd.2017.03.012","volume":"64","author":"A Sanchez-Valle","year":"2017","unstructured":"Sanchez-Valle A, Kassira N, Varela VC, Radu SC, Paidas C, Kirby RS (2017) Biliary atresia: epidemiology, genetics, clinical update, and public health perspective. Adv Pediatr 64:285\u2013305","journal-title":"Adv Pediatr"},{"key":"5009_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0022-3468(68)90897-X","volume":"3","author":"M Kasai","year":"1968","unstructured":"Kasai M, Kimura S, Asakura Y, Suzuki H, Taiba Y, Ohashi E (1968) Surgical treatment of biliary atresia. J Pediatr Surg 3:655\u2013675","journal-title":"J Pediatr Surg"},{"key":"5009_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13312-015-0735-6","volume":"52","author":"P Ramachandran","year":"2015","unstructured":"Ramachandran P, Safwan M, Reddy MS, Rela M (2015) Recent trends in the diagnosis and management of biliary atresia in developing countries. Indian Pediatr 52:871\u2013879","journal-title":"Indian Pediatr"},{"key":"5009_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.21790","volume":"46","author":"RJ Sokol","year":"2007","unstructured":"Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH (2007) Screening and outcomes in biliary atresia: summary of a national institutes of health workshop. Hepatology 46:566\u2013581","journal-title":"Hepatology"},{"issue":"2","key":"5009_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"issue":"1","key":"5009_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27(1):91\u2013105","journal-title":"Mol Cell"},{"issue":"1\u20132","key":"5009_CR8","first-page":"57","volume":"77","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K (2018) Next generation cancer therapy by microRNA drug discovery. Osaka Med Coll J 77(1\u20132):57\u201369","journal-title":"Osaka Med Coll J"},{"issue":"14","key":"5009_CR9","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3748\/wjg.15.1665","volume":"15","author":"XM Chen","year":"2009","unstructured":"Chen XM (2009) MicroRNA signatures in liver diseases. World J Gastroenterol 15(14):1665\u20131672","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5009_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1053\/j.gastro.2012.04.007","volume":"142","author":"XW Wang","year":"2012","unstructured":"Wang XW, Heegaard NH, Orum H (2012) MicroRNAs in liver disease. Gastroenterology 142(7):1431\u20131443","journal-title":"Gastroenterology"},{"issue":"20","key":"5009_CR11","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3748\/wjg.v17.i20.2536","volume":"17","author":"AM Lakner","year":"2011","unstructured":"Lakner AM, Bonkovsky HL, Schrum LW (2011) MicroRNAs: fad or future of liver disease. World J Gastroenterol 17(20):2536","journal-title":"World J Gastroenterol"},{"issue":"22","key":"5009_CR12","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3748\/wjg.v17.i22.2748","volume":"17","author":"G Maubach","year":"2011","unstructured":"Maubach G, Lim MCC, Chen J, Yang H, Zhuo L (2011) MiRNA studies in in vitro and in vivo activated hepatic stellate cells. World J Gastroenterol 17(22):2748\u20132773","journal-title":"World J Gastroenterol"},{"issue":"9","key":"5009_CR13","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yarushaimi N et al (2008) Serum microRNAs are promising novel biomakers. PLoS\u00a0One 3(9):e3148","journal-title":"PLoS\u00a0One"},{"key":"5009_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209\u2013218","journal-title":"Hepatology"},{"key":"5009_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbrc.2011.07.041","volume":"412","author":"Y Sekiya","year":"2011","unstructured":"Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N (2011) Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 412:74\u201379","journal-title":"Biochem Biophys Res Commun"},{"key":"5009_CR16","doi-asserted-by":"publisher","first-page":"e16081","DOI":"10.1371\/journal.pone.0016081","volume":"6","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K (2011) The progression of liver Fibrosis is related with overexpression of the miR-199 and 200 families. PLoS\u00a0One 6:e16081","journal-title":"PLoS\u00a0One"},{"key":"5009_CR17","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX (2016) Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 22:10512\u201310522","journal-title":"World J Gastroenterol"},{"key":"5009_CR18","first-page":"328","volume":"56","author":"HY Rao","year":"2009","unstructured":"Rao HY, Wei L, Li J, Zhang LF, Chen HY, Zhu LM, Liu F, Sun Y, Wang H (2009) Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response. Hepatogastroenterology 56:328\u2013334","journal-title":"Hepatogastroenterology"},{"issue":"7","key":"5009_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41419-018-0752-1","volume":"9","author":"L Ma","year":"2018","unstructured":"Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M et al (2018) MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis 9(7):718","journal-title":"Cell Death Dis"},{"issue":"36","key":"5009_CR20","doi-asserted-by":"publisher","first-page":"38705","DOI":"10.18632\/oncotarget.5478","volume":"6","author":"H Long","year":"2015","unstructured":"Long H, Wang Z, Chen J, Xiang T, Li Q, Diao X et al (2015) MicroRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu). Oncotarget 6(36):38705\u201338718","journal-title":"Oncotarget"},{"issue":"11","key":"5009_CR21","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/ijms17111795","volume":"17","author":"DA Calvopina","year":"2016","unstructured":"Calvopina DA, Coleman MA, Lewindon PJ, Ramm GA (2016) Function and regulation of microRNAs and their potential as biomarkers in pediatric liver disease. Int J Mol Sci 17(11):1795","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5009_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MPG.0b013e318264e648","volume":"55","author":"AM Zahm","year":"2012","unstructured":"Zahm AM, Hand NJ, Boateng LA, Friedman JR (2012) Circulating microRNA is a biomarker of biliary atresia. J Pediatr Gastroenterol Nutr 55(4):366\u2013369","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"5009_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MPG.0000000000001194","volume":"63","author":"X Peng","year":"2016","unstructured":"Peng X, Yang L, Liu H, Pang S, Chen Y, Fu J et al (2016) Identification of circulating microRNAs in biliary atresia by next-generation sequencing. J Pediatr Gastroenterol Nutr 63(5):518\u2013523","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5009_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","unstructured":"The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15\u201320","journal-title":"Hepatology"},{"issue":"2","key":"5009_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00535-016-1235-8","volume":"52","author":"N Yamada","year":"2017","unstructured":"Yamada N, Sanada Y, Tashiro M, Hirata Y, Okada N, Ihara Y et al (2017) Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol 52(2):245\u2013252","journal-title":"J Gastroenterol"},{"issue":"10","key":"5009_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00383-019-04535-9","volume":"35","author":"T Ueno","year":"2019","unstructured":"Ueno T, Kodama T, Noguchi Y, Nomura M, Saka R, Takama Y et al (2019) Serum Mac-2-binding protein (M2BPGi) as a marker of chronological liver fibrosis in biliary atresia patients with cirrhosis. Pediatr Surg Int 35(10):1065\u20131070","journal-title":"Pediatr Surg Int"},{"issue":"6","key":"5009_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43(6):1317\u20131325","journal-title":"Hepatology"},{"issue":"10","key":"5009_CR28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00383-018-4317-2","volume":"34","author":"T Ueno","year":"2018","unstructured":"Ueno T, Kodama T, Noguchi Y, Saka R, Tazuke Y, Bessho K et al (2018) Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia. Pediatr Surg Int 34(10):1065\u20131071","journal-title":"Pediatr Surg Int"},{"issue":"8","key":"5009_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL (2010) Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 7(8):425\u2013436","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"5009_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10620-016-4411-z","volume":"62","author":"D Zhao","year":"2017","unstructured":"Zhao D, Luo Y, Xia Y, Zhang JJ, Xia Q (2017) MicroRNA-19b expression in human biliary atresia specimens and its role in BA-related fibrosis. Dig Dis Sci 62(3):689\u2013698","journal-title":"Dig Dis Sci"},{"issue":"5","key":"5009_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/13031","volume":"1","author":"P Kogerman","year":"1999","unstructured":"Kogerman P, Grimm T, Kogerman L, Krause D, Unden AB, Sandstedt B et al (1999) Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol 1(5):312\u2013319","journal-title":"Nat Cell Biol"},{"key":"5009_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-cellbio-092910-154048","volume":"27","author":"CC Hui","year":"2011","unstructured":"Hui CC, Angers S (2011) Gli proteins in development and disease. Annu Rev Cell Dev Biol 27:513\u2013537","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"5009_CR33","first-page":"6077","volume":"15","author":"D Huang","year":"2018","unstructured":"Huang D, Wang Y, Tang J, Luo S (2018) Molecular mechanisms of suppressor of fused in regulating the hedgehog signaling pathway. Oncol Lett 15(5):6077\u20136086","journal-title":"Oncol Lett"},{"issue":"6","key":"5009_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0192623315573587","volume":"43","author":"T Izawa","year":"2015","unstructured":"Izawa T, Horiuchi T, Atarashi M, Kuwamura M, Yamate J (2015) Anti-fibrotic role of miR-214 in thioacetamide-induced liver cirrhosis in rats. Toxicol Pathol 43(6):844\u2013851","journal-title":"Toxicol Pathol"},{"issue":"6","key":"5009_CR35","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","volume":"38","author":"P Bedossa","year":"2013","unstructured":"Bedossa P, Darg\u00e8re D, Paradis V (2013) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38(6):1449\u20131457","journal-title":"Hepatology"},{"issue":"5","key":"5009_CR36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/MPG.0b013e3182a0c7a5","volume":"57","author":"BH Westheim","year":"2013","unstructured":"Westheim BH, Aagen\u00e6s I, \u00d8stensen AB, Sanenge T, Almaas R (2013) Effect of operator experience and frequency of procedure performance on complication rate after ultrasound-guided percutaneous liver biopsies. J Pediatr Gastroenterol Nutr 57(5):638\u2013643","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"5009_CR37","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00383-012-3183-6","volume":"28","author":"T Matsuura","year":"2012","unstructured":"Matsuura T, Kohashi K, Yanagi Y, Saeki I, Hayashida M, Aishima S et al (2012) A morphological study of the removed livers from patients receiving living donor liver transplantation for adult biliary atresia. Pediatr Surg Int 28(12):1171\u20131175","journal-title":"Pediatr Surg Int"},{"key":"5009_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61914-5","author":"K Fitzgerald","year":"2013","unstructured":"Fitzgerald K, Frank-Kamenetsky M, Shulga-Morskaya S et al (2013) Effect of an RNA interference drug on the synthesis of proprotein convertase subtillsin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomized, single-blind, placebo-controlled, phase 1 trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(13)61914-5","journal-title":"Lancet"},{"key":"5009_CR39","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, Zeuzm S, Rodrifuez-Trres M, Patel K et al (2013) Treatment of HCV infection by targeting microRNA. N Enfel J Med 368:1685\u20131694","journal-title":"N Enfel J Med"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-021-05009-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-021-05009-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-021-05009-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:06:15Z","timestamp":1641380775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-021-05009-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5009"],"URL":"https:\/\/doi.org\/10.1007\/s00383-021-05009-7","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"8 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from each patient (and\/or their parents) and controls regarding the use of liver and serum samples.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}